Target intelligence / Profile preview

EDRF1 antisense RNA 1 (EDRF1-AS1)

Target
EDRF1-AS1
Molecular classification
Other (long non-coding RNA, antisense RNA)
01

Overview

EDRF1 antisense RNA 1 (EDRF1-AS1) is a long non-coding RNA transcribed from the opposite strand of the EDRF1 gene. As an antisense RNA, it plays a regulatory role by inhibiting expression of the EDRF1 gene. Experimental studies in K562 erythroleukemia cells have shown that introducing EDRF1 antisense RNA downregulates GATA-1 transcription factor expression and DNA-binding activity, which impacts erythroid differentiation. Through these effects, EDRF1-AS1 modulates the expression of several cytokine receptors (such as IL-6 and GM-CSF receptors) and oncogenes (including c-Myc and c-kit), suggesting its involvement in cell proliferation and differentiation. To date, EDRF1-AS1 is not recognized as a classic therapeutic target or receptor, nor are there drugs in clinical use that interact with this molecule.

Other names
EDRF1-AS1antisense EDRF1 RNAantisense EDRF1 gene
02

Mechanism of action

Antisense inhibition of EDRF1, leading to decreased GATA-1 expression and altered differentiation pathways in erythroid cells. Antisense-mediated transcriptional interference and regulation.

03

Biological functions

Regulation of gene expression (at the transcriptional level)Modulation of erythroid proliferation and differentiationInhibition of GATA-1 transcription factor DNA-binding activity
04

Disease associations

Cancer (studies in K562 erythroleukemia cells)Potential roles in disorders of erythropoiesis, although not directly established in human disease
05

Safety considerations

Not established (no therapeutic targeting or clinical data)

Beyond the preview

Go deeper on EDRF1 antisense RNA 1 (EDRF1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EDRF1 antisense RNA 1 (EDRF1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call